Antibodies to intermediate filaments in polymyalgia rheumatica and giant cell arteritis: a sequential study
- PMID: 2446569
- PMCID: PMC1003381
- DOI: 10.1136/ard.46.10.746
Antibodies to intermediate filaments in polymyalgia rheumatica and giant cell arteritis: a sequential study
Abstract
Serum specimens from 35 patients with polymyalgia rheumatica and giant cell arteritis (PMR/GCA) were obtained sequentially at variable time intervals up to a year from onset of disease. These were tested for antibodies to intermediate filaments by indirect immunofluorescence using HEp2 cells as substrate. Twenty four of 35 (68%) patients' sera at onset of disease were positive at an anti-intermediate filament antibody (AIFA) titre of greater than 1/40 compared with three outs of 19 (15%) control sera. AIFA were predominantly of IgM class, and there was no significant change in AIFA titres on follow up despite clinical remission of disease.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
